Indeed, other cytokine replacement therapies, such as IFNγ, IFNα, IL-2, GM-CSF, and IL-12 have shown promise against TB, MDR-TB, MAC, and MABS [reviewed in Ref. This evidence concerns the gene IFNG and multidrug-resistant tuberculosis.